0
Regenxbio Inc. Banner Image

Regenxbio Inc. has reached its limit for free report views

Work for Regenxbio Inc.? Upgrade Your Profile and unlock all your annual reports.

Regenxbio Inc.

  • Ticker RGNX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Regenxbio Inc. Logo Image
  • 51-200 Employees
  • Based in Rockville, Maryland
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO’s NAV® Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology LicenseesMore are applying the NAV Technology Platform in the development of a broad pipeline of product candidates in multiple therapeutic areas.
Regenxbio Inc.

Most Recent Annual Report

Regenxbio Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Regenxbio Inc. has reached its limit for free report views.

Regenxbio Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports